20861373|t|Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.
20861373|a|Glial activation plays an important role in the pathogenesis of various neurodegenerative disorders including Alzheimer's disease. However, molecular mechanisms by which activated glia could kill neurons are poorly understood. The present study underlines the importance of neutral sphingomyelinase (N-SMase) in mediating the damaging effect of fibrillar amyloid-beta 1-42 (Abeta1-42) peptide-activated astroglia on neurons. In transwell experiments, soluble products released from activated primary human astroglia induced the activation of neutral sphingomyelinase (N-SMase), production of ceramide, and cell death in primary human neurons. Protection of neurons from cytotoxic effects of activated astroglia by antisense knockdown of N-SMase, but not acidic sphingomyelinase (A-SMase), suggests that soluble products released from activated astroglia kill neurons via N-SMase but not A-SMase. Next we examined the role of N-SMase in the activation of human astroglia. Interestingly, knockdown of N-SMase, but not A-SMase, by either antisense oligonucleotides or chemical inhibitor, prevented the induction of proinflammatory molecules [tumor necrosis factor-alpha, inducible nitric oxide synthase, interleukin-1beta (IL-1beta), and IL-6] and the activation of nuclear factor-kappaB in Abeta1-42-activated astroglia. Subsequently, fibrillar Abeta peptides also induced the activation of N-SMase and ceramide in vivo in mouse cortex. Most importantly, antisense knockdown of N-SMase, but not A-SMase, decreased the activation of astroglia and protected neurons from fibrillar Abeta toxicity in vivo in the cortex. Together, it is apparent that both the activation of astroglia by Abeta and that the cytotoxicity of activated astroglia on neurons depend on N-SMase.
20861373	10	22	amyloid-beta	Gene	351
20861373	33	38	human	Species	9606
20861373	62	67	human	Species	9606
20861373	80	104	neutral sphingomyelinase	Gene	6610
20861373	123	142	Alzheimer's disease	Disease	MESH:D000544
20861373	216	243	neurodegenerative disorders	Disease	MESH:D019636
20861373	254	273	Alzheimer's disease	Disease	MESH:D000544
20861373	418	442	neutral sphingomyelinase	Gene	6610
20861373	444	451	N-SMase	Gene	6610
20861373	644	649	human	Species	9606
20861373	686	710	neutral sphingomyelinase	Gene	6610
20861373	712	719	N-SMase	Gene	6610
20861373	736	744	ceramide	Chemical	MESH:D002518
20861373	772	777	human	Species	9606
20861373	814	823	cytotoxic	Disease	MESH:D064420
20861373	881	888	N-SMase	Gene	6610
20861373	898	921	acidic sphingomyelinase	Gene	6609
20861373	923	930	A-SMase	Gene	6609
20861373	1015	1022	N-SMase	Gene	6610
20861373	1031	1038	A-SMase	Gene	6609
20861373	1069	1076	N-SMase	Gene	6610
20861373	1098	1103	human	Species	9606
20861373	1143	1150	N-SMase	Gene	6610
20861373	1160	1167	A-SMase	Gene	6609
20861373	1189	1205	oligonucleotides	Chemical	MESH:D009841
20861373	1256	1271	proinflammatory	Disease	
20861373	1283	1310	tumor necrosis factor-alpha	Gene	7124
20861373	1345	1362	interleukin-1beta	Gene	3553
20861373	1364	1372	IL-1beta	Gene	3553
20861373	1379	1383	IL-6	Gene	3569
20861373	1487	1492	Abeta	Gene	351
20861373	1533	1540	N-SMase	Gene	6610
20861373	1545	1553	ceramide	Chemical	MESH:D002518
20861373	1565	1570	mouse	Species	10090
20861373	1620	1627	N-SMase	Gene	6610
20861373	1637	1644	A-SMase	Gene	6609
20861373	1721	1726	Abeta	Gene	351
20861373	1727	1735	toxicity	Disease	MESH:D064420
20861373	1825	1830	Abeta	Gene	351
20861373	1844	1856	cytotoxicity	Disease	MESH:D064420
20861373	1901	1908	N-SMase	Gene	6610
20861373	Association	MESH:D064420	6610
20861373	Positive_Correlation	351	6610
20861373	Positive_Correlation	3553	6610
20861373	Positive_Correlation	MESH:D002518	351
20861373	Association	MESH:D000544	351
20861373	Association	MESH:D000544	6610
20861373	Negative_Correlation	MESH:D009841	6610
20861373	Positive_Correlation	3569	6610
20861373	Positive_Correlation	6610	7124

